Practical Guidance for the Use of SGLT2 Inhibitors in Heart Failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Practical Guidance for the Use of SGLT2 Inhibitors in Heart Failure

Published:2023-08-24 Issue:6 Volume:23 Page:609-621
ISSN:1175-3277
Container-title:American Journal of Cardiovascular Drugs
language:en
Short-container-title:Am J Cardiovasc Drugs

Author:

Cavallari Ilaria,Crispino Simone Pasquale,Segreti Andrea,Ussia Gian Paolo,Grigioni Francesco

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40256-023-00601-9.pdf

Reference68 articles.

1. Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail. https://doi.org/10.1016/j.cardfail.2021.01.022(Epub 1 Mar 2021).

2. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858.

3. Jones NR, Roalfe AK, Adoki I, Hobbs FDR, Taylor CJ. Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis. Eur J Heart Fail. 2019;21(11):1306–25.

4. Cavallari I, Maddaloni E, Nusca A, Tuccinardi D, Buzzetti R, Pozzilli P, et al. SGLT-2 inhibitors on top of current pharmacological treatments for heart failure: a comparative review on outcomes and cost effectiveness. Am J Cardiovasc Drugs. 2022;22(3):263–70.

5. Cavallari I, Maddaloni E, Grigioni F. Implementing the treatment of heart failure with SGLT-2 inhibitors and sacubitril-valsartan: does money matter? Eur J Prev Cardiol. 2021;28(15):1670–2.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies;Cells;2024-09-01

2. Management of the liver transplant candidate with high cardiac risk: Multidisciplinary best practices and recommendations;Liver Transplantation;2024-05-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3